Nestlé Health Science Beats Expectations In Q1
Nestlé Health Science beat management's expectations in Q1 to post a solid organic sales rise despite facing a high comparative with the prior-year period. While Nestlé's group-wide sales were up in the three months, CEO Mark Schneider warned that further price rises were coming down the track, which would inevitably impact consumer spending.
You may also be interested in...
Nestlé CEO Mark Schneider says the company's consumer research indicates that the increase in dietary supplement usage over the past couple of years will endure post-pandemic. This continued demand help to lift sales at the company's Health Science business in the first half.
Nestlé Health Science continues to expand its dietary supplements offering in 2022 penning a deal for New Zealand's The Better Health Company and its GO Healthy brand. The company says the deal will strengthen its presence not just in New Zealand but across the wider APAC region in markets such as Australia and China.
Nestlé Health Science is expanding its offering in Brazil with the acquisition of dietary supplements and nutritional products player Puravida.